Methotrexate Determination Kit


Methotrexate Determination Kit (MTX Determination Kit) Abbreviation: MTX



Methotrexate Determination Kit is an in vitro diagnostic test for the quantitative detection of MTX in human serum and plasma specimens. Methotrexate is a folic acid antitumor drug that widely used in the treatment of malignant tumors such as acute lymphoblastic leukemia, lymphoma, chorionic epithelial cancer and osteosarcoma. High-dose methotrexate combined with calcium leucovorin is one of the important treatments for acute lymphoblastic leukemia, malignant lymphoma and osteosarcoma. High-dose methotrexate chemotherapy requires MTX blood concentration monitoring to guide the rational use of rescue drugs and avoid the serious side effects caused by MTX. Therefore, the monitoring of methotrexate blood concentration is a great significance for guiding the clinical rational use of drugs in cancer patients.